Contrast-enhanced near-infrared laser mammography with a prototype breast scanner: Feasibility study with tissue phantoms and preliminary results of imaging experimental tumors

Investigative Radiology

Volumn 36, Issue 10, 2001, Pages 573-581

  Boehm, Thomas ^a   Hochmuth, Albrecht ^b   Malich, Ansgar ^c   Reichenbach, Jurgen R ^c   Fleck, Marlies ^c   Kaiser, Werner A ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Animal trials; Contrast media; Laser mammography; VX2 tumor

Indexed keywords

CONTRAST MEDIUM; NIR 96010; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG ABSORPTION; EXPERIMENTAL NEOPLASM; FEMALE; INFRARED RADIATION; LASER; MAMMOGRAPHY; MOUSE; NONHUMAN; PHANTOM; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SPECTROMETRY;

EID: 0034793568     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200110000-00002     Document Type: Article

References (14)

1. Cancer statistics 1994
2. SEER cancer statistics review, 1973-1990
3. What's new in mammography
4. Mammographie und strahlenrisiko
5. Laser mammography with near-infrared light
6. Optical mammography in preoperative patients
7. Contrast media for optical mammography
8. Indocyanine green clearance as a test for hepatic function
9. Study on the suitability of a cyanine dye for indicator dilution technique and its application to the measurement of pulmonary artery and aortic flow
10. Synthesis and characterization of cyanine dye-poly(ethyleneglycol) conjugates as contrast agents for in vivo fluorescence imaging
11. In vivo characterization of cyanine dyes as contrast agents for near-infrared imaging
12. In vivo characterization of tissue efflux rates of cyanine dye by near-infrared spectroscopy
13. Laser mammography with NIR light
14. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging